Evidence map›Paper›PMID 33556114›Full record

ArticlePLoS pathogens2021

CVB3 VP1 interacts with MAT1 to inhibit cell proliferation by interfering with Cdk-activating kinase complex activity in CVB3-induced acute pancreatitis.

Hongxia Zhang, Lingbing Zeng, Qiong Liu, Guilin Jin, Jieyu Zhang, Zengbin Li, Yilian Xu, Huizhen Tian, Shanshan Deng, Qiaofa Shi and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Hongxia ZhangThe First Affiliated Hospital of Nanchang University, Nanchang, China.ORCID 0000-0001-5574-8284
Lingbing ZengThe First Affiliated Hospital of Nanchang University, Nanchang, China.ORCID 0000-0002-7073-0039
Qiong LiuDepartment of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.ORCID 0000-0002-8950-6133
Guilin JinThe Affiliated Hospital of JiangXi university of TCM, Nanchang, China.
Jieyu ZhangFuzhou Medical School of Nanchang University, Fuzhou, China.ORCID 0000-0002-4625-3359
Zengbin LiDepartment of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.ORCID 0000-0002-0237-4458
Yilian XuDepartment of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.ORCID 0000-0002-7377-458X
Huizhen TianDepartment of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.ORCID 0000-0001-5928-6355
Shanshan DengDepartment of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.ORCID 0000-0001-5988-833X
Qiaofa ShiDepartment of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.ORCID 0000-0002-0399-2346
Xiaotian HuangThe First Affiliated Hospital of Nanchang University, Nanchang, China.ORCID 0000-0003-1145-8386
Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coxsackievirus B3 (CVB3) belongs to the genus Enterovirus of the family Picornaviridae and can cause acute acinar pancreatitis in adults. However, the molecular mechanisms of pathogenesis underlying CVB3-induced acute pancreatitis have remained unclear. In this study, we discovered that CVB3 capsid protein VP1 inhibited pancreatic cell proliferation and exerted strong cytopathic effects on HPAC cells. Through yeast two-hybrid, co-immunoprecipitation, and confocal microscopy, we show that Menage a trois 1 (MAT1), a subunit of the Cdk-Activating Kinase (CAK) complex involved in cell proliferation and transcription, is a novel interaction protein with CVB3 VP1. Moreover, CVB3 VP1 inhibited MAT1 accumulation and localization, thus interfering with its interaction with CDK7. Furthermore, CVB3 VP1 could suppress CAK complex enzymic phosphorylation activity towards RNA Pol II and CDK4/6, direct substrates of CAK. VP1 also suppresses phosphorylation of retinoblastoma protein (pRb), an indirect CAK substrate, especially at phospho-pRb Ser780 and phospho-pRb Ser807/811 residues, which are associated with cell proliferation. Finally, we present evidence using deletion mutants that the C-terminal domain (VP1-D8, 768-859aa) is the minimal VP1 region required for its interaction with MAT1, and furthermore, VP1-D8 alone was sufficient to arrest cells in G1/S phase as observed during CVB3 infection. Taken together, we demonstrate that CVB3 VP1 can inhibit CAK complex assembly and activity through direct interaction with MAT1, to block MAT1-mediated CAK-CDK4/6-Rb signaling, and ultimately suppress cell proliferation in pancreatic cells. These findings substantially extend our basic understanding of CVB3-mediated pancreatitis, providing strong candidates for strategic therapeutic targeting.

Indexed as

Cell ProliferationCapsid ProteinsCell Cycle CheckpointsCell Cycle ProteinsCell DifferentiationCoxsackievirus InfectionsCyclin-Dependent Kinase-Activating KinaseCyclin-Dependent KinasesEnterovirus B, HumanHumansPancreatitisPhosphorylationTranscription FactorsCapsid ProteinsCell Cycle ProteinsCyclin-Dependent Kinase-Activating KinaseCyclin-Dependent KinasesMNAT1 protein, humanTranscription FactorsVP1 protein, enterovirus B

Identifiers

PMID33556114
PMCPMC7895353
OpenAlexW3128836922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.